What's in BioBalance Corporation's pipeline?

BioBalance Corporation has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with BioBalance Corporation's portfolio?

Top competitors by shared drug class: Biocodex, CD Pharma India Pvt. Ltd., CHU de Quebec-Universite Laval, Chuncheon Sacred Heart Hospital, Dow University of Health Sciences.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/biobalance-corporation.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

BioBalance Corporation — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BioBalance Corporation pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ProBactrix	ProBactrix	phase 3	Probiotic		Gastrointestinal

Therapeutic area mix

Gastrointestinal · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Biocodex · 1 shared drug class
CD Pharma India Pvt. Ltd. · 1 shared drug class
CHU de Quebec-Universite Laval · 1 shared drug class
Chuncheon Sacred Heart Hospital · 1 shared drug class
Dow University of Health Sciences · 1 shared drug class
Federico II University · 1 shared drug class
Fundación Hospital de Pediatría Prof. Dr. Juan P. Garrahan · 1 shared drug class
Aga Khan University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for BioBalance Corporation:

Cite this brief

Drug Landscape (2026). BioBalance Corporation — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/biobalance-corporation. Accessed 2026-05-16.